nach oben

Herzschrittmachertherapie + Elektrophysiologie

Erschienen in:

31.03.2021 | Schwerpunkt

ECG and arrhythmias in peripartum cardiomyopathy

verfasst von: PD Dr. David Duncker, Tobias J. Pfeffer, Johann Bauersachs, Christian Veltmann

Erschienen in: Herzschrittmachertherapie + Elektrophysiologie | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Peripartum cardiomyopathy (PPCM) is a rare but life-threatening heart disease, with onset in the last month of pregnancy or in the first months after delivery. Extensive studies on the burden of supraventricular and ventricular arrhythmias are lacking. Patients with PPCM present with electrocardiographic findings typical in acute heart failure. Management of arrhythmias in PPCM depends on the severity and the onset (during pregnancy or after delivery). Studies on the use of the wearable cardioverter–defibrillator in patients with PPCM show a substantial burden of ventricular tachyarrhythmias and sudden death in patients with severely reduced left ventricular function. The aim of the present article is to summarize actual knowledge on electrocardiogram findings, arrhythmias, and sudden cardiac death in patients with PPCM.

Bauersachs J, Arrigo M, Hilfiker-Kleiner D et al (2016) Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 18:1096–1105. https://doi.org/10.1002/ejhf.586CrossRefPubMed

Bauersachs J, König T, van der Meer P et al (2019) Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. Eur J Heart Fail 21:827–843. https://doi.org/10.1002/ejhf.1493CrossRefPubMed

DeBenedetti Zunino ME, Schuger C, Lahiri M (2014) High rate of ventricular arrhythmias in women with peripartum cardiomyopathy and implanted cardioverter defibrillators. J Am Coll Cardiol 63:A313. https://doi.org/10.1016/S0735-1097(14)60313-2CrossRef

Diao M, Diop IB, Kane A et al (2004) Electrocardiographic recording of long duration (Holter) of 24 hours during idiopathic cardiomyopathy of the peripartum. Arch Mal Coeur Vaiss 97:25–30PubMed

Duncker D, Haghikia A, König T et al (2014) Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator. Eur J Heart Fail 16:1331–1336. https://doi.org/10.1002/ejhf.188CrossRefPubMed

Duncker D, Westenfeld R, Konrad T et al (2017) Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis. Clin Res Cardiol 12:767–768. https://doi.org/10.1007/s00392-017-1090-5CrossRef

Ekizler FA, Cay S, Kafes H et al (2019) The prognostic value of positive T wave in lead aVR: a novel marker of adverse cardiac outcomes in peripartum cardiomyopathy. Ann Noninvasive Electrocardiol 24:e12631. https://doi.org/10.1111/anec.12631CrossRefPubMedPubMedCentral

Ersbøll AS, Johansen M, Damm P et al (2017) Peripartum cardiomyopathy in Denmark: a retrospective, population-based study of incidence, management and outcome. Eur J Heart Fail 19:1712–1720. https://doi.org/10.1002/ejhf.882CrossRefPubMed

Goland S, Modi K, Bitar F et al (2009) Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail 15:645–650. https://doi.org/10.1016/j.cardfail.2009.03.008CrossRefPubMed

10.

Hilfiker-Kleiner D, Haghikia A, Berliner D et al (2017) Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study. Eur Heart J 38:2671–2679. https://doi.org/10.1093/eurheartj/ehx355CrossRefPubMedPubMedCentral

11.

Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J (2015) Peripartum cardiomyopathy: current management and future perspectives. Eur Heart J 36:1090–1097. https://doi.org/10.1093/eurheartj/ehv009CrossRefPubMedPubMedCentral

12.

Hilfiker-Kleiner D, Kaminski K, Podewski E et al (2007) A cathepsin D‑cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128:589–600. https://doi.org/10.1016/j.cell.2006.12.036CrossRefPubMed

13.

Hoevelmann J, Viljoen CA, Manning K et al (2019) The prognostic significance of the 12-lead ECG in peripartum cardiomyopathy. Int J Cardiol 276:177–184. https://doi.org/10.1016/j.ijcard.2018.11.008CrossRefPubMed

14.

Honigberg MC, Elkayam U, Rajagopalan N et al (2019) Electrocardiographic findings in peripartum cardiomyopathy. Clin Cardiol 42:524–529. https://doi.org/10.1002/clc.23171CrossRefPubMedPubMedCentral

15.

Karaye KM, Lindmark K, Henein MY (2016) Electrocardiographic predictors of peripartum cardiomyopathy. Cardiovasc J Afr 27:66–70. https://doi.org/10.5830/CVJA-2015-092CrossRefPubMedPubMedCentral

16.

Krexi D, Sheppard MN (2017) Cardiovascular causes of maternal sudden death. Sudden arrhythmic death syndrome is leading cause in UK. Eur J Obstet Gynecol Reprod Biol 212:155–159. https://doi.org/10.1016/j.ejogrb.2017.03.006CrossRefPubMed

17.

Labidi S, Hilfiker-Kleiner D, Klein G (2011) Left bundle branch block during pregnancy as a sign of imminent peripartum cardiomyopathy. Eur Heart J 32:1076. https://doi.org/10.1093/eurheartj/ehq487CrossRefPubMed

18.

Laghari AH, Khan AH, Kazmi KA (2013) Peripartum cardiomyopathy: ten year experience at a tertiary care hospital in Pakistan. BMC Res Notes 6:495. https://doi.org/10.1186/1756-0500-6-495CrossRefPubMedPubMedCentral

19.

Mallikethi-Reddy S, Akintoye E, Trehan N et al (2017) Burden of arrhythmias in peripartum cardiomyopathy: analysis of 9841 hospitalizations. Int J Cardiol 235:114–117. https://doi.org/10.1016/j.ijcard.2017.02.084CrossRefPubMed

20.

Mbakwem AC, Bauersachs J, Viljoen C et al (2021) Electrocardiographic features and their echocardiographic correlates in peripartum cardiomyopathy: results from the ESC EORP PPCM registry. ESC Heart Fail 97:25. https://doi.org/10.1002/ehf2.13172CrossRef

21.

Ntusi NBA, Badri M, Gumedze F et al (2015) Pregnancy-associated heart failure: a comparison of clinical presentation and outcome between hypertensive heart failure of pregnancy and idiopathic Peripartum Cardiomyopathy. Plos One 10:e133466. https://doi.org/10.1371/journal.pone.0133466CrossRefPubMedPubMedCentral

22.

Opotowsky AR, Siddiqi OK, D’Souza B et al (2012) Maternal cardiovascular events during childbirth among women with congenital heart disease. Heart 98:145–151. https://doi.org/10.1136/heartjnl-2011-300828CrossRefPubMed

23.

Pfeffer TJ, Klüsch V, Duncker D et al (2020) Long-term follow-up of patients with peripartum cardiomyopathy and an implantable cardioverter defibrillator—a multicenter study. Clin Res Cardiol 109:V639. https://doi.org/10.1007/s00392-020-01621-0CrossRef

24.

Ponikowski P, Voors AA, Anker SD et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. https://doi.org/10.1093/eurheartj/ehw128CrossRefPubMedPubMedCentral

25.

Priori SG, Blomström-Lundqvist C, Mazzanti A et al (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 17:1601–1687. https://doi.org/10.1093/europace/euv319CrossRefPubMed

26.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J et al (2018) 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 39:3165–3241. https://doi.org/10.1093/eurheartj/ehy340CrossRefPubMed

27.

Saltzberg MT, Szymkiewicz S, Bianco NR (2012) Characteristics and outcomes of peripartum versus nonperipartum cardiomyopathy in women using a wearable cardiac defibrillator. J Card Fail 18:21–27. https://doi.org/10.1016/j.cardfail.2011.09.004CrossRefPubMed

28.

Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767–778. https://doi.org/10.1093/eurjhf/hfq120CrossRefPubMed

29.

Sliwa K, Petrie MC, van der Meer P et al (2020) Clinical presentation, management, and 6‑month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry. Eur Heart J 41:3787–3797. https://doi.org/10.1093/eurheartj/ehaa455CrossRefPubMedPubMedCentral

30.

Tanaka H, Katsuragi S, Osato K et al (2017) The increase in the rate of maternal deaths related to cardiovascular disease in Japan from 1991–1992 to 2010–2012. J Cardiol 69:74–78. https://doi.org/10.1016/j.jjcc.2016.01.005CrossRefPubMed

31.

Tibazarwa K, Lee G, Mayosi B et al (2012) The 12-lead ECG in peripartum cardiomyopathy. Cardiovasc J Afr 23:322–329. https://doi.org/10.5830/CVJA-2012-006CrossRefPubMedPubMedCentral

32.

Vaidya VR, Arora S, Patel N et al (2017) Burden of Arrhythmia in Pregnancy. Circulation 135:619–621. https://doi.org/10.1161/CIRCULATIONAHA.116.026681CrossRefPubMed

Titel: ECG and arrhythmias in peripartum cardiomyopathy
verfasst von: PD Dr. David Duncker
Tobias J. Pfeffer
Johann Bauersachs
Christian Veltmann
Publikationsdatum: 31.03.2021
Verlag: Springer Medizin
Erschienen in: Herzschrittmachertherapie + Elektrophysiologie / Ausgabe 2/2021
Print ISSN: 0938-7412
Elektronische ISSN: 1435-1544
DOI: https://doi.org/10.1007/s00399-021-00760-9

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Atrial fibrillation during pregnancy: a 9-month period with limited options

Antiarrhythmic drugs—safety and efficacy during pregnancy

Catheter mapping and ablation during pregnancy

Pregnancy in patients with implantable cardiac defibrillators